STEMCELL Technologies Opens New Office and Laboratories in Cambridge, UK
STEMCELL Technologies UK has recently celebrated the grand opening of their Cambridge-based facility. Founded by Dr. Allen Eaves, STEMCELL provides specialized reagents and tools that support research on cancer and other diseases, as well as cell therapy and regenerative medicine globally. Cambridge is a leading global hub for stem cell research. This, combined with its proximity to STEMCELL’s customers in the UK and Europe, makes the location a natural choice for continued investment by the company.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170131005406/en/
STEMCELL recently took possession of an 18,000 square foot building located in the Cambridge Research Park. STEMCELL has now consolidated existing UK staff into the facility, which at full capacity will house a substantial Research and Development group, as well as Sales, Marketing and other support staff.
A major focus of the new facility will be a state-of-the-art Education and Teaching Lab. STEMCELL offers several standard and customized training courses and workshops, which are currently hosted within collaborating academic lab facilities. The multi-day, interactive courses are designed to help researchers develop expertise in protocols and techniques supported by STEMCELL’s products. Several of these world-class courses will soon be offered in the new Cambridge facility, making them more accessible to researchers in the UK and Europe.
Dr. Allen Eaves, CEO and President of STEMCELL Technologies, commented:
“STEMCELL is committed to driving the advancement of science by offering the highest quality products and services to support scientists with their research. We are thrilled to be officially opening our new Cambridge office, including our Research and Development labs and Education Centre. STEMCELL has seen fantastic growth, and this facility will take us to the next level in supporting medical sciences research globally, as well as open our doors to the incredible biomedical expertise in the UK and Europe.”
About STEMCELL Technologies
As a company of Scientists Helping Scientists, STEMCELL Technologies is committed to providing high-quality reagents, tools and services supporting life sciences research. Scientists performing stem cell, immunology, cancer, regenerative medicine and cellular therapy research rely on STEMCELL’s cell culture media, cell separation products, instruments, accessory reagents, and scientific services. Driven by science and a passion for quality, over 2500 STEMCELL products are available to researchers worldwide.
Andrew Booth, Chief Commercial Officer
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
NJ-CELGENE17.2.2018 22:02 | pressemeddelelse
OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçet’s Disease with Oral Ulcers
CELLTRION-HEALTHCARE17.2.2018 09:02 | pressemeddelelse
CT-P13 (biosimilar infliximab) is comparable to reference infliximab and adalimumab in highly anticipated real-world study
AVANTI-COMMUNICATIONS16.2.2018 19:28 | pressemeddelelse
Avanti Communications HYLAS 4 Satellite Arrives in French Guiana
KY-GENERAL-CABLE-CORP16.2.2018 18:07 | pressemeddelelse
General Cable Corporation Stockholders Approve Acquisition By Prysmian Group
BOEHRINGER-INGELHEIM16.2.2018 10:05 | pressemeddelelse
Systemic Sclerosis World Congress: Inspirational Patient Stories Reveal the Challenging Realities of Living with Devastating Rare Disease
PHILIP-MORRIS-INTL16.2.2018 09:02 | pressemeddelelse
Philip Morris International Recognized as a Global Top Employer for the Second Year in a Row
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum